Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: A randomized controlled trial

European Urology

Volumn 63, Issue 1, 2013, Pages 158-165

  Kaplan, Steven A ^a   He, Weizhong ^b   Koltun, William D ^c   Cummings, Jana ^b   Schneider, Tim ^d   Fakhoury, Allam ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^c Medical Center for Clinical Research   (United States)

^d PUR/R Praxisklinik Urologie Rhein Ruhr   (Germany)

Author keywords

Bladder outlet obstruction; Lower urinary tract symptoms; Solifenacin; Tamsulosin

Indexed keywords

PLACEBO; SOLIFENACIN; TAMSULOSIN;

ADULT; ARTICLE; BLADDER CATHETERIZATION; BLADDER CONTRACTILE INDEX SCORE; BLADDER NECK STENOSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTICENTER STUDY; POSTVOID RESIDUAL URINE VOLUME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; URINARY URGENCY; URINE FLOW RATE; URINE INCONTINENCE; URINE RETENTION; URINE VOLUME; XEROSTOMIA;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; AGED; ANALYSIS OF VARIANCE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PRESSURE; QUINUCLIDINES; SULFONAMIDES; TETRAHYDROISOQUINOLINES; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION; URODYNAMICS;

EID: 84870560801     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.07.003     Document Type: Article

References (22)

1. D.E. Irwin, I. Milsom, and S. Hunskaar Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 2006 1306 1315 discussion 1314-5
2. R. Rosen, J. Altwein, and P. Boyle Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7) Eur Urol 44 2003 637 649
3. C.C. Sexton, K.S. Coyne, and Z.S. Kopp The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS BJU Int 103 Suppl 3 2009 12 23
4. K.S. Coyne, C.C. Sexton, D.E. Irwin, Z.S. Kopp, C.J. Kelleher, and I. Milsom The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study BJU Int 101 2008 1388 1395
5. C.R. Chapple, and C.G. Roehrborn A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder Eur Urol 49 2006 651 659
6. G.E. Lemack Defining the role of overactive bladder treatments in men with lower urinary tract symptoms Nat Clin Pract Urol 4 2007 174 175
7. B.T. Blake-James, A. Rashidian, Y. Ikeda, and M. Emberton The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis BJU Int 99 2007 85 96
8. S.A. Kaplan, C.G. Roehrborn, E.S. Rovner, M. Carlsson, T. Bavendam, and Z. Guan Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial JAMA 296 2006 2319 2328
9. S.A. Kaplan, K. McCammon, R. Fincher, A. Fakhoury, and W. He Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency J Urol 182 2009 2825 2830
10. P. Abrams Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function BJU Int 84 1999 14 15
11. S.A. Kaplan, C.G. Roehrborn, P. Abrams, C.R. Chapple, T. Bavendam, and Z. Guan Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review Int J Clin Pract 65 2011 487 507
12. C. Chapple, S. Herschorn, P. Abrams, F. Sun, M. Brodsky, and Z. Guan Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with α-blockers Eur Urol 56 2009 534 543
13. O. Yamaguchi, H. Kakizaki, and Y. Homma Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms - ASSIST, randomized controlled study Urology 78 2011 126 133
14. O. Nishizawa, O. Yamaguchi, M. Takeda, O. Yokoyama TAABO Study Group Randomized controlled trial to treat benign prostatic hyperplasia with overactive bladder using an alpha-blocker combined with anticholinergics LUTS: Lower Urinary Tract Symptoms 3 2011 29 35
15. A. Athanasopoulos, C. Chapple, and C. Fowler The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update Eur Urol 60 2011 94 105
16. P. Abrams, S. Kaplan, H.J. De Koning Gans, and R. Millard Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction J Urol 175 2006 999 1004 discussion 1004
17. A study with combination treatment [tamsulosin hydrochloride and solifenacin succinate] in male patients with LUTS/BPH (SATURN) [identifier NCT00510406 ]. ClinicalTrials.gov Web site. http://clinicaltrials.gov/ct2/show/ NCT00510406.
18. C. Chapple Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia Curr Opin Urol 20 2010 43 48
19. K.S. Lee, M.S. Choo, and D.Y. Kim Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study J Urol 174 2005 1334 1338
20. S.A. Kaplan, C.G. Roehrborn, J. Gong, F. Sun, and Z. Guan Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms BJU Int 109 2012 1831 1840
21. Van Kerrebroeck P, Oelke M, Katona F, Garcia-Hernandez A, Klaver M. Efficacy of tamsulosin OCAS plus solifenacin (TOCAS plus soli) in male LUTS: results from a randomised, dose-ranging, Phase II trial (SATURN). Poster presented at: Société Internationale d'Urologie World Meeting on Lower Urinary Tract Dysfunction; October 13-16, 2010; Marrakech, Morocco.
22. M.J. Marberger, J.T. Andersen, and J.C. Nickel Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention: Combined experience from three large multinational placebo-controlled trials Eur Urol 38 2000 563 568